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IntroductIon
Spinal cord injury results in significant neuronal loss 
with dramatic, irreversible functional deficit. “Sec-
ondary degeneration” is a term that describes the ex-
pansion of neuronal degeneration to cell populations 
that exist in the vicinity of the initial mechanical trau-
ma, thus escaping the lesion1-3. This phenomenon is 
attributed to the release from the injured cells of high 
levels of toxic molecules which act on the cell bod-
ies, dendrites and axons of the adjacent, non-injured, 
neurons4-6. Glutamic acid, free radicals and other neu-
rotoxic factors have been implicated for the develop-
ment of secondary degeneration3,6. This finding yields 
the necessity for treatment modalities directed to the 
rescue of neurons that initially escape the mechanical 
injury but potentially die due to the deleterious effects 
of secondary degeneration. 
It is well established that surgical alignment, in 
the presence of fracture, and methylprednizolone 
administration are both important modalities in the 
management of acute spinal cord injuries. Methyl-
prednizolone diminishes the cascade of secondary de-
generation and this is the reason for which previous 
studies concluded that the accumulation of inflamma-
tory cells in the area of trauma is a key factor for the 
inhibition of neural tissue regeneration7,8. Other stud-
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ies in the field of neurodegeneration have questioned 
this assumption claiming that presence of inflamma-
tory cells after the injury may benefit the regeneration 
process of the neural tissue, the final outcome being 
actually the result of a competition between a “pro-
tective” and a “destructive” role of the inflammatory 
cells9-15. More recently, it has been shown that T cells 
directed against myelin antigens (autoreactive T cells) 
express a similar double role: they are destructive in 
case of demyelinating diseases, but protective in case 
of spinal cord injury16-18.
Most of the aforementioned studies dealt with 
exogenously administrated auto-reactive T lympho-
cytes. In our study, we investigate the role of the en-
dogenously activated anti-myelin T cells due to active 
immunization, following experimental spinal cord 
injury. Experimental autoimmune encephalomyelitis 
was used in order to induce active immunization. Ac-
cording to this experimental model, CD4 T lympho-
cytes are activated against CNS myelin antigens, such 
as MBP. After their activation they cross the blood-
brain barrier (BBB) and produce diffuse inflammatory 
reaction in the white matter of the brain and spinal 
cord. The disease is monophasic that is after a while 
it remisses without any subsequent deficit. Depend-
ing to the experimental model (antigen nature, animal 
specie), demyelination follows the inflammatory reac-
tion. 
Our results revealed that the presence of activated 
T cells promotes the clinical improvement and restores 
the neurologic deficit of the injured animals. 
MaterIals and Methods
Animals
Female adult Lewis rats (6-8 weeks old, 180-200gr) 
were supplied by Charles River GmbH, Sulzfeld, 
Germany, and maintained in our pathogen-free animal 
facility. The rats were housed in a light- and temper-
ature-controlled room and matched for age in each 
experiment. 
Thirty Lewis rats were divided into three groups 
(A, B, and C) of ten (Table 1).
Group A consisted of 10 rats without SCI. In this 
group EAE was induced and was used as a control 
group in order to evaluate the grade of muscle weak-
ness produced by the inflammation itself. Group B 
consisted of 10 rats with both EAE and SCI. Group 
C consisted of 10 rats with SCI only that is without 
previous EAE induction. 
Fifteen of these rats (5 of each group) were sacri-
ficed on DPI 15, whereas the other 15 were sacrificed 
on DPI 20 following the induction of EAE. 
Induction of EAE.
EAE induction was performed by subcutaneous in-
jection of 50mg MBP 72-85 (guinea pig myelin basic 
protein, Sigma, St. Louis, MO) in the plantar surface 
of one hindlimb19. MBP was dissolved in 200μl of 
Table 1. Experimental design.
Group a
(acute EAE)
Group B
(acute EAE + SCI)
Group c
(SCI)
Day 0
EAE induction (MBP)
Day 0
EAE induction (MBP)
5th, 6th, 7th day
BrdU 10mg/rat/day 
5th, 6th, 7th day
BrdU 10mg/rat/day 
5th, 6th, 7th day
BrdU 10mg/rat/day 
8th day
SCI (T8-T9 level)
15th or 20th day
Sacrifice
Spinal cord fixation
8th day
SCI (T8-T9 level)
15th or 20th day
Sacrifice
Spinal cord fixation
Histological study
Immunocytochemistry
15th or 20th day
Sacrifice
Spinal cord fixation
Histological study
Immunocytochemistry
Histological study
Immunocytochemistry
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incomplete Freund’s adjuvant containing mycobac-
terium tuberculosis H37Ra (6mg/ml) (Difco Labo-
ratories, Detroit, MI) and PBS (Phosphate Buffered 
Saline, pH 7,4). 
Spinal cord injury at the midthoracic level
Experimental SCI was performed under general anes-
thesia (Xylazin, Ketamine) using a stereotactic micro-
scope (Zeiss). After skin incision and spine exposure 
at the midthoracic level, a laminectomy of T8 and T9 
was performed. Following that, the spinal cord was 
compressed by applying an extradural temporary an-
eurysmatic clip with closure force of 35g for 1min20-22. 
According to the relative literature this protocol re-
sults in a medium-to-severe injury. 
Post-operatively all of the animals received antibi-
otic treatment (intraperitoneal injection of Gentamy-
cin). 
Clinical assessment.
Clinical signs of EAE were graded daily on an arbitrary 
scale of 1 to 619. (Table 2). Functional recovery was 
determined by locomotor hindlimb performance. This 
was scored with the open-field locomotor rating scale 
of Basso, Beattie, and Bresnahan (BBB) on a scale 
of 0 (complete paralysis) to 21 (normal mobility)23. 
Twice a week, the locomotor activity of the trunk, tail, 
and hindlimbs was evaluated, in an open field by plac-
ing the animal for 4 min in the centre of a circular 
enclosure (90 cm in diameter, 7 cm wall height). Each 
hind limb was scored by two investigators blinded to 
the treatment protocol. Individual hind limb scores 
were averaged to provide a single score for each ani-
mal per session. 
Animal care
In injured rats the bladder expression was assisted 
manually twice a day (three times per day during the 
first 48 hours after injury) until the end of the second 
week, by which time automatic voidance had been re-
covered. Rats were monitored carefully for evidence 
of urinary tract infection or any other sign of systemic 
disease. Daily inspections included examination of 
the laminectomy site for evidence of infection and as-
sessment of the hindlimbs for signs of autophagia or 
pressure. Such animals were excluded from the study. 
Animals were followed up for 15 or 20 days following 
the induction of EAE.
In vivo BrdU inorporation of activated T lympho-
cytes
In order to identify T cell proliferation, 5-Bromo-2′-
Deoxyuridine (BrdU, 10 mg/ml PBS) was intrave-
nously administered in animals in vivo, during the 
last 3 days prior to the SCI. Those days were actually 
the 5th, 6th and 7th day following EAE induction in the 
corresponding subgroups. BrdU study of the animals 
with EAE induction only, provided evidence of the 
presence or absence of SCI-induced T cell activation/
proliferation. 
Histopathological study 
Rats were sacrificed at DPI 15 and 20. All animals 
were anaesthetized with ether and were perfused with 
ice-cold PBS followed by ice-cold 4% paraformalde-
hyde in PBS, through transcardial perfusion. Spinal 
cords were removed by surgical excision of vertebra 
lamella and kept in 4% paraformaldehyde in PBS for 
a 4-hour post-fixation. Tissues were then prepared for 
Table 2. Clinical scale for the evaluation of EAE.
Clinical score Clinical feature
0 No overt disease
1 Limp tail
2 Paresis of 1 or 2 limbs
3 Unilateral hindlimb paralysis
4 Bilateral hindlimb paralysis
5 Bilateral hindlimb paralysis and incontinence
6 Death
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cryostat sections according to standard procedures. 
Sections of 6μm were cut and used for histological 
and immunohistological evaluation.
Quantification of the inflammatory process in both 
acute and chronic groups was performed in Hematox-
ylin-Eosin sections at arbitrary predefined levels of 
hemispheres, brain stem and spinal cord. At least 5 
sections were evaluated for each one of above CNS 
areas. Sections were evaluated under 10x optical 
fields. An observer blinded to treatment and clinical 
severity, evaluated the total number of perivascular 
mononuclear infiltrates for each section. Data were 
then used to evaluate a) the number of infiltrating cells 
per perivascular infiltrations, per group, b) number of 
perivascular infiltrations per group, c) number of infil-
trating cells per group.
Quantification of the inflammatory process and ax-
onal pathology in both acute and chronic groups was 
performed in sections stained with a modified Biel-
schowsky silver stain method counterstained with He-
matoxylin, performed in our laboratory and based on 
the modification suggested by Litchfield and Nagy24. 
According to this modification incubations were per-
formed in 4°C for 35 minutes and incubation and de-
veloping solutions were carefully prepared to reach a 
specific pH for each solution. All sections were then 
counterstained with Hematoxylin. This modification 
allowed simultaneous evaluation of the axonal pa-
thology along with the inflammatory process in each 
section. Comparisons of the results obtained from our 
Bielschowsky modification with those of the classic 
Hematoxylin-Eosin revealed that EAE infiltrations 
were estimated reliably with either of the two methods 
and both methods revealed the same number of infil-
trations and infiltrated cells in adjacent sections. Thus, 
our modification of Bielschowsky silver staining with 
Hematoxylin counterstaining was preferred for the 
simultaneous evaluation of inflammation and axonal 
pathology, on the same section, in both groups. 
The evaluation of inflammation was performed by 
counting the total number of perivascular mononuclear 
infiltrates for each section and data were used to eval-
uate a) the number of infiltrating cells per perivascular 
infiltrations, per group, b) number of perivascular in-
filtrations per group, c) number of infiltrating cells per 
group. For axonal injury we used an ordinal graded 
scale from 0 to 4, were we applied 0 for normal axonal 
morphology and 4 for severe axonal injury. Moreover, 
for axonal loss we also used a similar ordinal graded 
scale from 0 to 4, where 0 was for normal axonal den-
sity and 4 for total absence of axons.
BrdU immunohistochemistry revealed the prolif-
erating T-cells. Briefly, 6 μm spinal cord sections were 
incubated in 0.3% H2O2 in methanol for 15 min. After 
TBS washes, the sections were incubated in 0.1 mg/
ml proteinase K for 10min. The sections were treated 
with 2N HCl for 30 min and washed to neutralize the 
pH. Sections were incubated with anti-BrdU (clone 
Bu20a, Dako, 1:400 dilution) overnight at 4°C. A goat 
anti-mouse IgG secondary antibody (Serotec) was 
added for 1 hour at room temperature. Counterstain-
ing was done with Hematoxylin.
Statistics
Statistics were performed using the SPSS 11.5 soft-
ware. For clinical and histopathological scale data we 
initially tested their normality using Shapiro-Wilk and 
Kolmogorov-Smirnov normality tests in order to as-
sess the criterion of normality for t-student test appli-
cation. Wherever data were found to violate the nor-
mality assumption and a logarithmic transformation 
could not apply normality we used the non-parametric 
equivalent Mann-Whitney U test for comparison of 
the two groups. Wherever the criteria for t-test were 
met we performed the t-test for comparison of the two 
groups taken care to use the right p depending on the 
equality or not of the variances. For nominal or ordi-
nal data we used a chi-square test for comparison of 
the two groups. Results were considered as “statistical 
significant” at the level of p < 0,05 and values are ex-
pressed as mean ± SD.
results
Clinical evaluation
In the group with pure SCI without previous active 
EAE induction the mean BBB varied from 0 (on DPI 
1) to 3,8 (on DPI 15) and 4,6 (on DPI 20). In the other 
group, in which SCI was preceded by active EAE in-
duction, the mean BBB varied from 0 (on DPI 1) to 
4,8 (on DPI 15) and 9,8 (on DPI 20).
Mean values of BBB for both groups are shown in 
Table 3 and are schematically represented in Figure 
1.
On DPI 15 there was no significant difference in lo-
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comotor activity between the animals of group B (SCI 
+ EAE) and C (SCI only). Thereafter, the animals of 
group B presented a remarkable improvement of their 
locomotor skills, whereas the animals of group C con-
tinued deteriorating. This difference was more prompt 
between DPI 18 and 20 (p < 0.05). 
The animals of group A (EAE only) presented a 
score of no more than 1 in the relative scale for EAE 
evaluation which is equal to a flaccid paralysis of the 
limb. This finding suggests that EAE did not influence 
the clinical condition of the animals. 
Histological study
The animals with pure EAE presented typical diffuse 
perivascular infiltrations in the white matter of spinal 
cord (Figure 1A). In the animals with EAE and SCI 
such infiltrations were shown to accumulate in the area 
of trauma enriching the trauma-induced inflammation 
with extra inflammatory elements (Figure 1B). 
The cavity due to the trauma was larger in ani-
mals without EAE (Figure 1C), but the extension of 
infiltrations in this group was similar or even smaller 
compared to the animals with SCI plus EAE (Figure 
1D). These findings suggest that the size of the trauma 
cavity and inflammatory infiltration are not necessar-
ily linearly correlated (Figure 1C and D, 3A and C).
BrdU is a useful index for identifying cells that 
are actively divided. This way we were able to lo-
cate reactive T lymphocytes in the examined spinal 
cord tissue (Figure 2A). In periphery, EAE-induced T 
lymphocytes initially activated against MBP and then 
Table 3. Mean values of BBB score of Group B and C.
daYs Post InductIon 
oF eae
dPI 
1
dPI
8
dPI
10
dPI
12
dPI
15
dPI
18
dPI
20
GROUP B 0 0 0,6 2,9 4,9 7,6 9,8
GROUP C 0 0 0,6 2,7 3,8 4,2 4,6
Figure 1. Clinical assessment (BBB score) of group B (EAE 
+ SCI) animals which exhibited significantly better clinical 
scores when compared to group C (SCI) animals.
Figure 2. Distribution of inflammatory cells, Α: in EAE 
animals inflammatory infiltrates were distributed mainly 
perivascularly (arrows) whereas, Β: in EAE+SCI animals 
inflammatory cells were distributed diffusely (asterisks). 
The size of the traumatic cavity was bigger in SCI animals 
(C), compared to those where EAE was also induced (D). 
Red-dotted line highlights the injury related cavity, whereas 
the Green-dotted-one indicates the outer limits of the trau-
ma.
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start to invade the CNS. These lymphocytes, due to 
their high proliferation rate, incorporate BrdU and can 
be located by immunocytochemistry under light mi-
crosope (Figure 2B).
Our findings suggest that BrdU+ cells were almost 
exclusively related to EAE and not to SCI (Figure 
3A,B). The SCI itself failed to provide massive in-
flammatory infiltrations. On the other hand, the EAE-
induced inflammatory cells accumulated in the area of 
trauma (Figure 3C,D) and not diffusely in the spinal 
cord as normally expected (Figure 2B). These find-
ings are consistent with the fact that the EAE-induced 
inflammatory cells exacerbate the inflammatory infil-
tration process in the area of trauma.
On DPI 20 using Bielschowsky staining we found 
that animals of group C (SCI without EAE) presented 
extensive neuronal injury and loss (Figure 4A). On the 
other hand, animals of group B (SCI plus EAE) had a 
significant number of preserved neurons (Figure 4B). 
dIscussIon
Our results imply that autoimmunity can be potential-
ly neuroprotective after a sustained spinal cord injury. 
Endogenously produced inflammatory cells activated 
against myelin antigens are selectively accumulated 
in the area of trauma thus boosting the initial trauma-
induced inflammatory process. Under these circum-
stances the animals present better clinical outcome 
with less neurologic deficit. This clinical finding was 
further supported by the identification of significantly 
more preserved axons in the animals with SCI plus 
EAE.
The research about the role of inflammation in the 
neurologic recovery following CNS trauma was trig-
gered by the finding that regeneration of neural tissue 
is much more prominent in peripheral nervous system 
(PNS) than in CNS. 
Previous studies have shown that significant dif-
ferences exist in the inflammatory process taking 
place in PNS and CNS after trauma. Macrophage 
invasion in trauma area is slower and less extensive 
following PNS trauma25. Additionally, macrophages 
invading the CNS are less capable for phagocytosis 
of the injured myelin26. Macrophages of the CNS en-
vironment, that is microglia, even though activated 
following mechanical trauma have minor compared 
to the macrophages in periphery and lasts less long27. 
Figure 3. Proliferating inflammatory cells marked with 
BrdU immunohistochemistry: BrdU is incorporated in the 
nucleus of the divided cell (A). BrdU – positive cells maybe 
identified as perivascular infiltrates (B).
 Figure 4. Inflammatory reaction in SCI (A; B, higher mag-
nification) and SCI plus EAE-induction (C; D, higher mag-
nification) as indicated by BrdU incorporation. In animals 
with SCI-only, monocytes positively stained for BrdU could 
hardly be detected (arrow in B) whereas the co-existence of 
SCI with EAE was characterized by massive accumulation 
of BdU – positive inflammatory cells at the area of trauma, 
indicating their clear relation to EAE, though not the SCI. 
Cells that were negative for BrdU were counterstained with 
Hematoxylin.
Figure 5. Axonal injury and loss as indicated with Biel-
schowsky’s silver impregnation staining, in SCI (Α) and 
during the co-existense of SCI with EAE (Β). Evidently, 
higher axonal preservation as well as reduced number of 
axons undergoing degeneration (arrows) (B) is attributed 
to EAE-related inflammatory cells (Hematoxylin counter-
staining).
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Finally, transplantation of activated macrophages in 
the area of trauma has been proved to be beneficial for 
the regeneration process13.
Summarizing, it seems that we have to reconsider 
the role of inflammation in cases of CNS trauma. Tra-
ditionally this role was believed to be destructive but 
there are upcoming evidences for a different, protec-
tive action. Inflammatory cells may promote the re-
covery and regeneration of traumatized neural tissue 
recruiting mechanisms that are still under investiga-
tion. 
During the last decade there’s been a growing 
debate about the protective role of autoimmunity in 
CNS lesions.18 It has been shown that lymphocytes 
activated against CNS antigens release neurotrophic 
factors such as Brain Derived Growth Factor (BDNF) 
and promote the survival of neural cells in vitro28,29.
Our results support the assumption that there is a 
neuroprotective role of inflammation after CNS trau-
ma. We confirmed the presence of significant percent-
age of preserved axons in the case of EAE and SCI 
coexistence. This finding was correlated with a better 
clinical outcome of the animals. 
There are various experimental questions that need 
to be addressed. Which elements of inflammation must 
be promoted? Which of them must be eliminated? It’s 
obvious that we have to find the appropriate “thera-
peutic window” for a given intervention and also the 
equilibrium between neuroprotective autoimmunity 
and induction or exacerbation of an autoimmune dis-
order. A rational approach would be a well controlled, 
time-limited boosting of selective autoimmune reac-
tions. 
Abbreviations: BrdU = 5-Bromo-2-deoxyuridine; CNS = 
central nervous system; DPI = day post-induction; EAE 
= experimental allergic encephalomyelitis; MBP = myelin 
basic protein; SCI = spinal cord injury.
ΠΕΡΙΛΗΨΗ: Η φλεγμονή που αναπτύσσεται μετά από τραυματική κάκωση του κεντρικού νευρικού συστήματος (ΚΝΣ) 
συμβάλλει σημαντικά στην καταστροφή που επέρχεται στον τραυματισμένο ιστό. Βρέθηκε ωστόσο ότι εξωγενώς χορηγούμενα 
Τ- λεμφοκύτταρα τα οποία προηγουμένως έχουν εργοποιηθεί έναντι αντιγόνων της μυελίνης, προσφέρουν νευροπροστασία 
μετά από κάκωση του ΚΝΣ. Οι παρατηρήσεις αυτές οδήγησαν στην άποψη περί του προστατευτικού ρόλου της φλεγμονής. 
Υπάρχει όμως περιορισμένη έρευνα σχετικά με το αν η ενδογενώς προκαλούμενη φλεγμονή, δηλαδή η ενεργητική, αυτο-
ανοσοποίση, μπορεί να προσφέρει τα ίδια αποτελέσματα. Στη μελέτη αυτή ερευνάται η κινητικότητα και η επίδραση των 
ενδογενώς ενεργοποιημένων Τ-λεμφοκυττάρων έναντι της μυελίνης στην αποκατάσταση του νωτιαίου μυελού (ΝΜ) μετά από 
κάκωση. Προκλήθηκε πειραματική αυτοάνοση εγκεφαλομυελίτιδα (ΠΑΕ) σε επίμυες φυλής Lewis μετά από ανοσοποίηση 
έναντι της βασικής πρωτεΐνης της μυελίνης, (MBP). Υπό τις συνθήκες αυτές, τα ενεργοποιημένα Τ-λεμφοκύτταρα σημάν-
θηκαν με Bρόμο-δεοξυ-ουριδίνη (BrdU) in vivo. Η BrdU χορηγήθηκε στα πειραματόζωα κατά τις ημέρες 5, 6 και 7. Την 8η 
μέρα, προκλήθηκε ημιδιατομή του ΝΜ με τοποθέτηση ανευρυσματικού κλιπ στο Θ8 επίπεδο. Τα πειραματόζωα εξετάστηκαν 
κλινικά καθημερινά μετά την ημέρα της κάκωσης. Η κάκωση του ΝΜ είχε ως αποτέλεσμα τη σπαστική παράλυση του ομό-
πλευρου οπισθίου άκρου. Η κλινική αποκατάσταση ήταν σημαντικά καλύτερη στα πειραματόζωα με ΠΑΕ. Ενεργοποιημένα 
μονοπύρηνα κύτταρα ήταν συγκεντρωμένα εκλεκτικά στην περιοχή της κάκωσης. Η απώλεια των νευραξόνων λόγω της 
κάκωσης ήταν μικρότερη στην ομάδα των επίμυων με ΠΑΕ. Τα αποτελέσματα αυτά είναι ενδεικτικά του ότι η ενεργητική 
αυτοανοσία κατά του ΚΝΣ μπορεί να ασκεί νευροπροστασία μετά από μηχανικό τραυματισμό.
Λέξεις Κλειδιά: Τραυματική κάκωση νωτιαίου μυελού, Πειραματική αλλεργική εγκεφαλομυελίτιδα, Νευροπροστασία, 
Αποκατάσταση.
Νευροπροστασία από τη φλεγμονή. Η Πειραματική Αλλεργική Εγκεφαλομυελίτιδα 
διευκολύνει την αποκατάσταση μετά από τραυματική κάκωση του νωτιαίου μυελού.
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